US Patent Issued to Pinetree Therapeutics on July 28 for "Bispecific antibodies comprising an NRP1 binding domain and methods of use thereof" (Massachusetts Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,315, issued on July 28, was assigned to Pinetree Therapeutics Inc. (Cambridge, Mass.).

"Bispecific antibodies comprising an NRP1 binding domain and methods of use thereof" was invented by Ho-Juhn Song (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides bispecific antibodies, and compositions and methods of treating cancer incorporating said bispecific antibodies. The bispecific antibodies include a polypeptide comprising an EGFR-binding domain and a neuropilin (NRP1)-specific binding domain at the C-terminal end. Monoclonal antibodies that specifically bind NRP1 are also provided."

The patent was filed o...